{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T20:40:05Z","timestamp":1760992805916,"version":"build-2065373602"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03801-8","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T07:46:44Z","timestamp":1760946404000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Log odds of negative lymph nodes\/T stage as a novel predictor of post-resection outcome in non\u2013small cell lung cancer patients"],"prefix":"10.1007","volume":"16","author":[{"given":"Liu","family":"Shao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoyang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,20]]},"reference":[{"issue":"3","key":"3801_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"3801_CR2","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/s41571-021-00501-4","volume":"18","author":"JE Chaft","year":"2021","unstructured":"Chaft JE, Rimner A, Weder W, Azzoli CG, Kris MG, Cascone T. Evolution of systemic therapy for stages I-III non-metastatic non-small-cell lung cancer. Nat Rev Clin Oncol. 2021;18(9):547\u201357.","journal-title":"Nat Rev Clin Oncol"},{"key":"3801_CR3","doi-asserted-by":"crossref","unstructured":"Deboever N, Mitchell KG, Feldman HA, Cascone T, Sepesi B. Current surgical indications for Non-Small-Cell lung cancer. Cancers (Basel). 2022;14(5).","DOI":"10.3390\/cancers14051263"},{"issue":"25","key":"3801_CR4","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1200\/JCO.2017.72.4401","volume":"35","author":"MG Kris","year":"2017","unstructured":"Kris MG, Gaspar LE, Chaft JE, et al. Adjuvant systemic therapy and adjuvant radiation therapy for stage I to IIIA completely resected Non-Small-Cell lung cancers: American society of clinical Oncology\/Cancer care Ontario clinical practice guideline update. J Clin Oncol. 2017;35(25):2960\u201374.","journal-title":"J Clin Oncol"},{"issue":"1","key":"3801_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","volume":"11","author":"P Goldstraw","year":"2016","unstructured":"Goldstraw P, Chansky K, Crowley J, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11(1):39\u201351.","journal-title":"J Thorac Oncol"},{"issue":"2","key":"3801_CR6","first-page":"138","volume":"67","author":"R Rami-Porta","year":"2017","unstructured":"Rami-Porta R, Asamura H, Travis WD, Rusch VW. Lung cancer - major changes in the American joint committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(2):138\u201355.","journal-title":"CA Cancer J Clin"},{"key":"3801_CR7","doi-asserted-by":"crossref","unstructured":"Kamigaichi A, Aokage K, Katsumata S et al. Prognostic impact of examined mediastinal lymph node count in clinical N0 non-small cell lung cancer. Eur J Cardiothorac Surg. 2022;62(2).","DOI":"10.1093\/ejcts\/ezac359"},{"issue":"20","key":"3801_CR8","doi-asserted-by":"publisher","first-page":"e15645","DOI":"10.1097\/MD.0000000000015645","volume":"98","author":"H Liu","year":"2019","unstructured":"Liu H, Yan T, Zhang T, Chen X, Wang Y, Du J. Proposal of a new nodal classification for operable non-small cell lung cancer based on the number of negative lymph nodes and the anatomical location of metastatic lymph nodes. Med (Baltim). 2019;98(20):e15645.","journal-title":"Med (Baltim)"},{"issue":"5","key":"3801_CR9","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00408-020-00378-7","volume":"198","author":"X Zhou","year":"2020","unstructured":"Zhou X, Wu C, Cheng Q. Negative lymph node count predicts survival of resected Non-small cell lung cancer. Lung. 2020;198(5):839\u201346.","journal-title":"Lung"},{"issue":"11","key":"3801_CR10","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1200\/JCO.2016.67.5140","volume":"35","author":"W Liang","year":"2017","unstructured":"Liang W, He J, Shen Y, et al. Impact of examined lymph node count on precise staging and Long-Term survival of resected Non-Small-Cell lung cancer: A population study of the US SEER database and a Chinese Multi-Institutional registry. J Clin Oncol. 2017;35(11):1162\u201370.","journal-title":"J Clin Oncol"},{"issue":"4","key":"3801_CR11","doi-asserted-by":"publisher","first-page":"e563","DOI":"10.1016\/j.cllc.2020.09.015","volume":"22","author":"Z He","year":"2021","unstructured":"He Z, Li Z, Xu S, et al. Prognostic significance of lymph node count removed at sublobar resection in pathologic stage IA Non-Small-cell lung cancer: A Population-Based analysis. Clin Lung Cancer. 2021;22(4):e563\u2013563573.","journal-title":"Clin Lung Cancer"},{"key":"3801_CR12","doi-asserted-by":"publisher","first-page":"153303382210745","DOI":"10.1177\/15330338221074506","volume":"21","author":"X Huang","year":"2022","unstructured":"Huang X, Hu P, Yan F, Zhang J. Establishment and validation of a nomogram based on negative lymph nodes to predict survival in postoperative patients with non-Small cell lung cancer. Technol Cancer Res Treat. 2022;21:15330338221074506.","journal-title":"Technol Cancer Res Treat"},{"issue":"3","key":"3801_CR13","doi-asserted-by":"publisher","first-page":"4497","DOI":"10.2217\/fon-2019-0367","volume":"16","author":"Z Liang","year":"2020","unstructured":"Liang Z, Wang X, Yang H, et al. Different prognostic significance of examined lymph node count for patients with non-small-cell lung cancer\u2009\u2264\u20091\u00a0cm or >\u20091\u20132\u00a0cm: a population-based study. Future Oncol. 2020;16(3):4497\u2013509.","journal-title":"Future Oncol"},{"issue":"12","key":"3801_CR14","doi-asserted-by":"publisher","first-page":"6569","DOI":"10.21037\/jtd.2018.11.49","volume":"10","author":"Y Liu","year":"2018","unstructured":"Liu Y, Shen J, Liu L, et al. Impact of examined lymph node counts on survival of patients with stage IA non-small cell lung cancer undergoing sublobar resection. J Thorac Dis. 2018;10(12):6569\u201377.","journal-title":"J Thorac Dis"},{"issue":"45","key":"3801_CR15","doi-asserted-by":"publisher","first-page":"79387","DOI":"10.18632\/oncotarget.18154","volume":"8","author":"S Wang","year":"2017","unstructured":"Wang S, Zhang B, Li C, et al. Prognostic value of number of negative lymph node in patients with stage II and IIIa non-small cell lung cancer. Oncotarget. 2017;8(45):79387\u201396.","journal-title":"Oncotarget"},{"issue":"1","key":"3801_CR16","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jtcvs.2018.03.113","volume":"156","author":"S Yendamuri","year":"2018","unstructured":"Yendamuri S, Dhillon SS, Groman A, et al. Effect of the number of lymph nodes examined on the survival of patients with stage I non-small cell lung cancer who undergo sublobar resection. J Thorac Cardiovasc Surg. 2018;156(1):394\u2013402.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3801_CR17","doi-asserted-by":"publisher","first-page":"895413","DOI":"10.3389\/fonc.2022.895413","volume":"12","author":"T Chen","year":"2022","unstructured":"Chen T, Zhan X, Chen X, et al. Predictive value of the log odds of negative lymph Nodes\/T stage as a novel prognostic factor in bladder cancer patients after radical cystectomy. Front Oncol. 2022;12:895413.","journal-title":"Front Oncol"},{"issue":"8","key":"3801_CR18","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1007\/s00432-021-03654-y","volume":"147","author":"J Xie","year":"2021","unstructured":"Xie J, Pang Y, Li X, Wu X. The log odds of negative lymph nodes\/T stage: a new prognostic and predictive tool for resected gastric cancer patients. J Cancer Res Clin Oncol. 2021;147(8):2259\u201369.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"8","key":"3801_CR19","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1007\/s11605-022-05408-8","volume":"26","author":"W Yang","year":"2022","unstructured":"Yang W, Lu S, Ge F, Hua Y, Chen X. Prognostic and predictive model of the log odds of the negative lymph Node\/T stage ratio in resectable gastric adenocarcinoma patients. J Gastrointest Surg. 2022;26(8):1743\u201356.","journal-title":"J Gastrointest Surg"},{"issue":"10","key":"3801_CR20","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1007\/s40520-021-01835-w","volume":"33","author":"J Geng","year":"2021","unstructured":"Geng J, Deng L, Qiu S, et al. Low lean mass and cognitive performance: data from the National health and nutrition examination surveys. Aging Clin Exp Res. 2021;33(10):2737\u201345.","journal-title":"Aging Clin Exp Res"},{"issue":"5","key":"3801_CR21","doi-asserted-by":"publisher","first-page":"e968","DOI":"10.1016\/j.clgc.2019.05.011","volume":"17","author":"X Liao","year":"2019","unstructured":"Liao X, Qiu S, Zheng X, et al. Lymph node density as an independent prognostic factor in node-Positive Renal-Cell carcinoma: results from the Surveillance, Epidemiology, and end results program. Clin Genitourin Cancer. 2019;17(5):e968\u2013968980.","journal-title":"Clin Genitourin Cancer"},{"issue":"6","key":"3801_CR22","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1016\/j.athoracsur.2020.04.117","volume":"110","author":"AJ Rucker","year":"2020","unstructured":"Rucker AJ, Raman V, Jawitz OK, et al. Effect of lymph node assessment on outcomes in surgery for limited stage small cell lung cancer. Ann Thorac Surg. 2020;110(6):1854\u201360.","journal-title":"Ann Thorac Surg"},{"issue":"11","key":"3801_CR23","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1016\/j.numecd.2021.07.002","volume":"31","author":"Y Xiong","year":"2021","unstructured":"Xiong Y, Wangsheng F, Wang S, et al. Positive association between body fat percentage and hyperuricemia in patients with hypertension: the China H-type hypertension registry study. Nutr Metab Cardiovasc Dis. 2021;31(11):3076\u201384.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"21","key":"3801_CR24","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10(21):7252\u20139.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"3801_CR25","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/ejcts\/ezab287","volume":"60","author":"H Yang","year":"2021","unstructured":"Yang H, Mei T. The prognostic value of lymph node ratio in patients with surgically resected stage I-III small-cell lung cancer: a propensity score matching analysis of the SEER database. Eur J Cardiothorac Surg. 2021;60(5):1212\u201320.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"9","key":"3801_CR26","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1007\/s00432-019-02976-2","volume":"145","author":"Y Li","year":"2019","unstructured":"Li Y, Hu S, Xie J, et al. Effects of surgery on survival of elderly patients with stage I small-cell lung cancer: analysis of the SEER database. J Cancer Res Clin Oncol. 2019;145(9):2397\u2013404.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"3801_CR27","doi-asserted-by":"publisher","first-page":"e441","DOI":"10.1016\/j.cllc.2017.05.005","volume":"18","author":"S Nakamichi","year":"2017","unstructured":"Nakamichi S, Horinouchi H, Asao T, et al. Comparison of radiotherapy and chemoradiotherapy for locoregional recurrence of Non-small-cell lung cancer developing after surgery. Clin Lung Cancer. 2017;18(6):e441\u2013441448.","journal-title":"Clin Lung Cancer"},{"issue":"8","key":"3801_CR28","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1007\/s40520-022-02112-0","volume":"34","author":"H Yang","year":"2022","unstructured":"Yang H, Xiao X, Mei T, Zhou P. Long-term survival analysis of sublobar resection versus lobectomy for older patients with early-stage pulmonary carcinoid tumour: a database-based propensity score-matched study. Aging Clin Exp Res. 2022;34(8):1925\u201334.","journal-title":"Aging Clin Exp Res"},{"issue":"11","key":"3801_CR29","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1002\/cncr.24989","volume":"116","author":"Z Sun","year":"2010","unstructured":"Sun Z, Xu Y, de Li M, et al. Log odds of positive lymph nodes: a novel prognostic indicator superior to the number-based and ratio-based N category for gastric cancer patients with R0 resection. Cancer. 2010;116(11):2571\u201380.","journal-title":"Cancer"},{"issue":"2","key":"3801_CR30","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10120-016-0601-9","volume":"20","author":"T Sano","year":"2017","unstructured":"Sano T, Coit DG, Kim HH, et al. Proposal of a new stage grouping of gastric cancer for TNM classification: international gastric cancer association staging project. Gastric Cancer. 2017;20(2):217\u201325.","journal-title":"Gastric Cancer"},{"issue":"2","key":"3801_CR31","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1245\/s10434-006-9218-2","volume":"14","author":"RE Schwarz","year":"2007","unstructured":"Schwarz RE, Smith DD. Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage. Ann Surg Oncol. 2007;14(2):317\u201328.","journal-title":"Ann Surg Oncol"},{"issue":"28","key":"3801_CR32","doi-asserted-by":"publisher","first-page":"7114","DOI":"10.1200\/JCO.2005.14.621","volume":"23","author":"DD Smith","year":"2005","unstructured":"Smith DD, Schwarz RR, Schwarz RE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol. 2005;23(28):7114\u201324.","journal-title":"J Clin Oncol"},{"issue":"6975","key":"3801_CR33","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1136\/bmj.310.6975.298","volume":"310","author":"DG Altman","year":"1995","unstructured":"Altman DG, Bland JM. Statistics notes: the normal distribution. BMJ. 1995;310(6975):298.","journal-title":"BMJ"},{"issue":"1","key":"3801_CR34","first-page":"12","volume":"15","author":"JW Osborne","year":"2010","unstructured":"Osborne JW. Improving your data transformations: applying the Box-Cox transformation. Pract Assess Res Eval. 2010;15(1):12.","journal-title":"Pract Assess Res Eval"},{"key":"3801_CR35","doi-asserted-by":"crossref","unstructured":"Harrell FE Jr. Regression modeling strategies: with applications to linear Models, logistic Regression, and survival analysis. Springer; 2015.","DOI":"10.1007\/978-3-319-19425-7"},{"issue":"2","key":"3801_CR36","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s11605-012-1974-7","volume":"17","author":"NP Valsangkar","year":"2013","unstructured":"Valsangkar NP, Bush DM, Michaelson JS, et al. N0\/N1, N1, or N2? The effect of lymph node number on accurate staging of pancreatic ductal adenocarcinoma. J Gastrointest Surg. 2013;17(2):257\u201366.","journal-title":"J Gastrointest Surg"},{"issue":"36","key":"3801_CR37","doi-asserted-by":"publisher","first-page":"6166","DOI":"10.1200\/JCO.2009.23.7958","volume":"27","author":"M G\u00f6nen","year":"2009","unstructured":"G\u00f6nen M, Schrag D, Weiser MR. Nodal staging score: a tool to assess adequate staging of node-negative colon cancer. J Clin Oncol. 2009;27(36):6166\u201371.","journal-title":"J Clin Oncol"},{"issue":"2","key":"3801_CR38","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.2517-6161.1958.tb00292.x","volume":"20","author":"DR Cox","year":"1958","unstructured":"Cox DR. The regression analysis of binary sequences. J R Stat Soc Ser B Stat Methodol. 1958;20(2):215\u201332.","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"issue":"2","key":"3801_CR39","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/JTO.0b013e3181c814e7","volume":"5","author":"JY Douillard","year":"2010","unstructured":"Douillard JY, Tribodet H, Aubert D, et al. Adjuvant cisplatin and Vinorelbine for completely resected non-small cell lung cancer: subgroup analysis of the lung adjuvant cisplatin evaluation. J Thorac Oncol. 2010;5(2):220\u20138.","journal-title":"J Thorac Oncol"},{"issue":"25","key":"3801_CR40","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1056\/NEJMoa043623","volume":"352","author":"T Winton","year":"2005","unstructured":"Winton T, Livingston R, Johnson D, et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med. 2005;352(25):2589\u201397.","journal-title":"N Engl J Med"},{"issue":"5","key":"3801_CR41","doi-asserted-by":"publisher","first-page":"643","DOI":"10.6004\/jnccn.2014.0068","volume":"12","author":"RW Carlson","year":"2014","unstructured":"Carlson RW, Larsen JK, McClure J, et al. International adaptations of NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2014;12(5):643\u20138.","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"3801_CR42","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/1759-7714.13685","volume":"12","author":"P Zhang","year":"2021","unstructured":"Zhang P, Duan J, Bai H, et al. Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non-small cell lung cancer. Thorac Cancer. 2021;12(1):30\u20139.","journal-title":"Thorac Cancer"},{"issue":"4","key":"3801_CR43","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.21037\/jtd.2018.03.184","volume":"10","author":"HJ Park","year":"2018","unstructured":"Park HJ, Park HS, Cha YJ, et al. Efficacy of adjuvant chemotherapy for completely resected stage IB non-small cell lung cancer: a retrospective study. J Thorac Dis. 2018;10(4):2279\u201387.","journal-title":"J Thorac Dis"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03801-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03801-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03801-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T20:03:22Z","timestamp":1760990602000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03801-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,20]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3801"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03801-8","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,20]]},"assertion":[{"value":"18 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As the SEER database comprises deidentified and publicly available information and does not involve the use of personal identifying data, approval fromthe institutional review board and ethics committee was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1922"}}